Australia markets close in 2 hours 6 minutes

Lexaria Bioscience Corp. (LEXX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1200+0.2400 (+8.33%)
At close: 04:00PM EDT
3.1988 +0.08 (+2.53%)
After hours: 06:17PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
31/08/2019
Cash flows from operating activities
Net income
-5,440
-6,665
-7,269
-4,027
-3,934
-
Depreciation & amortisation
140.647
145.397
102.718
147.597
146.092
-
Stock-based compensation
145.033
170.382
752.591
410.007
1,139
-
Change in working capital
-378.708
143.264
-351.475
63.526
-194.363
-
Accounts receivable
-268.853
26.539
-137.491
189.58
-90.78
-
Inventory
9.356
43.069
-1.979
95.037
4.213
-
Accounts payable
-
88.492
50.726
13.803
-49.491
-
Other working capital
-5,408
-6,051
-5,060
-4,069
-2,652
-
Other non-cash items
44.194
43.791
1,244
92.912
109.665
-
Net cash provided by operating activities
-5,209
-5,881
-4,879
-3,990
-2,619
-
Cash flows from investing activities
Investments in property, plant and equipment
-199.1
-169.61
-180.64
-79.493
-33.645
-
Acquisitions, net
-
-
-
-
-
0
Sales/maturities of investments
-
-
-
0
6.802
0
Other investing activities
-
-
-49.192
273.373
-
-
Net cash used for investing activities
-199.1
-169.61
-180.64
193.88
-26.843
-
Cash flows from financing activities
Debt repayment
-
0
-44.6
-66.694
-44.496
-
Common stock issued
5,798
1,590
0
9,471
2,668
-
Other financing activities
-
-
-
-
-
1,000
Net cash used provided by (used for) financing activities
6,862
1,590
-44.6
13,420
2,654
-
Net change in cash
1,433
-4,461
-5,105
9,624
8.602
-
Cash at beginning of period
3,272
5,813
10,918
1,294
1,285
-
Cash at end of period
4,726
1,352
5,813
10,918
1,294
-
Free cash flow
Operating cash flow
-5,209
-5,881
-4,879
-3,990
-2,619
-
Capital expenditure
-199.1
-169.61
-180.64
-79.493
-33.645
-
Free cash flow
-5,408
-6,051
-5,060
-4,069
-2,652
-